Mostrar el registro sencillo del ítem

dc.contributor.author
Vázquez, Stella Maris  
dc.contributor.author
Mladovan, Alejandro Gustavo  
dc.contributor.author
Perez, Cecilia  
dc.contributor.author
Bruzzone, Ariana  
dc.contributor.author
Baldi, Alberto  
dc.contributor.author
Luthy, Isabel Alicia  
dc.date.available
2017-11-18T11:47:12Z  
dc.date.issued
2006-07  
dc.identifier.citation
Vázquez, Stella Maris; Mladovan, Alejandro Gustavo; Perez, Cecilia; Bruzzone, Ariana; Baldi, Alberto; et al.; Human breast cell lines exhibit functional a2-adrenoceptors; Springer Verlag Berlín; Cancer Chemotherapy And Pharmacology; 58; 1; 7-2006; 50-61  
dc.identifier.issn
0344-5704  
dc.identifier.uri
http://hdl.handle.net/11336/28533  
dc.description.abstract
Adrenergic compounds (epinephrine and norepinephrine) are the most important hormones released during stress. Several different receptors are associated with their action in different tissues. However, Alpha2-adrenoceptors have not yet been described in either normal or tumour human breast tissue. The aim of this work was to describe and characterize these receptors in several tumour and non-tumour human cell lines. The expression of Alpha2-adrenoceptors was analyzed at the RNA (RT-PCR) and protein ([3H]-rauwolscine binding and immunocytochemistry) levels in different human breast cell lines, and the biological activity assessed by [3H]-thymidine incorporation. The cancer IBH-6, IBH-7 and MCF-7 and the non-tumour HBL-100 cells line, expressed both Alpha2B- and Alpha2C-adrenoceptor-subtypes. A single subtype was expressed in malignant HS-578T (Alpha2A) and MDA-MB-231 and non-tumour MCF-10A cells (Alpha2B). All cell lines exhibited significant binding for the specific antagonist [3H]-rauwolscine. The Alpha-, Alpha2-, and the Alpha1-compounds with known affinity for Alpha2-adrenoceptors, including epinephrine, norepinephrine, yohimbine, clonidine, rauwolscine and prazosin, competed significantly with binding in MCF-7 cells. In addition, IBH-6, IBH-7 and MCF-7 cells showed significant staining with specific antibodies against Alpha2B and Alpha2C-adrenoceptor subtypes, when tested by immunocytochemistry. In all cell lines, the specific agonist clonidine or oxymetazoline stimulated [3H]-thymidine incorporation. EC50 values were in the range of 20-50 fM for IBH-6, IBH-7, and HS-578T; 0.14 pM for MCF-7; 2-82 pM for HBL-100 and MCF-10A cells, and a biphasic behaviour with a maximum value at 38.0 pM, was observed for MDA-MB-231 cells. The specific Alpha2-adrenergic antagonist rauwolscine always reversed this stimulation at 0.1 nM. In conclusion, this study describes for the first time, the presence of Alpha2-adrenoceptors in human epithelial breast cell lines. Moreover, activation of these receptors was associated with an enhancement of cell proliferation.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Springer Verlag Berlín  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Breast Cancer  
dc.subject
Cell Proliferation  
dc.subject
Clonidine  
dc.subject
Rawolscine  
dc.subject
Receptors Adrenergic  
dc.subject.classification
Patología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Bioquímica y Biología Molecular  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Human breast cell lines exhibit functional a2-adrenoceptors  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-10-26T14:40:17Z  
dc.identifier.eissn
1432-0843  
dc.journal.volume
58  
dc.journal.number
1  
dc.journal.pagination
50-61  
dc.journal.pais
Alemania  
dc.journal.ciudad
Heidelberg  
dc.description.fil
Fil: Vázquez, Stella Maris. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina  
dc.description.fil
Fil: Mladovan, Alejandro Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina  
dc.description.fil
Fil: Perez, Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina  
dc.description.fil
Fil: Bruzzone, Ariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina  
dc.description.fil
Fil: Baldi, Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina  
dc.description.fil
Fil: Luthy, Isabel Alicia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina  
dc.journal.title
Cancer Chemotherapy And Pharmacology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007%2Fs00280-005-0130-4  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/10.1007/s00280-005-0130-4  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/purl/16292538